27 FEB 2019 | DARMSTADT, GERMANY $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-stock Proposal Merck KGaA, Darmstadt, Germany, a leading science and technology company, today delivered a letter to the Board of Directors of Versum Materials, Inc. (“Versum”), outlining the terms of a superior proposal to acquire Versum for $48 per share... Read more
FEBRUARY 26, 2019 MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and Ning Zhou, CEO of Lisen, attended the meeting and signing ceremony. Bio-Techne is a leading provider of high-quality... Read more
Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech Agreement ensures consistent supply of nucleotides, enzymes and other critical raw materials for messenger RNA (mRNA) vaccine manufacturing platform WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a multi-year agreement with Mainz,... Read more
Basel, 25 February 2019 Roche enters into definitive merger agreement to acquire Spark Therapeutics Roche to acquire Spark Therapeutics for US$ 114.50 per share Spark Therapeutics is a leader in discovering, developing and delivering gene therapies with one commercial asset and four programmes currently in clinical trials Transaction expected to close in Q2, 2019 Roche... Read more
February 20, 2019 Robust, High-Throughput Solutions Help Cannabis Testing Facilities to Support Product Quality and Consumer Safety while Reducing Turnaround Times Reno, Nev. (February 20, 2019) – Hamilton Robotics and Medicinal Genomics continue to combine their respective strengths to benefit the rapidly expanding and evolving cannabis testing market. As such, assay technologies based on Medicinal... Read more
Hilden, Germany, Holzgerlingen, Germany, and Vienna, Austria, February 18, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V. (Euronext: CURE), to develop innovative bioinformatics and assay solutions to accelerate research targeting the growing global health challenges posed by antibiotic-resistant bacteria. QIAGEN... Read more
FRANKLIN LAKES, N.J., Feb. 15, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at Leerink Partners 8th Annual Global Healthcare Conference on Thursday, February 28, 2019, at 10:00 a.m. ET. A live webcast of BD’s presentation can be accessed from the BD... Read more
BERWYN, Pa., Feb. 13, 2019 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has increased the authorized level for repurchases of its common stock by $500 million. This increased authorization will be added to the approximately $1 million that currently remains available from an existing authorization approved by the Board... Read more
Middleton, WI (Feb 13, 2019). Gilson announces a new partnership with AFFINISEP to distribute AFFINISEP’s line of sample preparation and extraction products. The products and services complement Gilson’s ASPEC® line of automated solid phase extraction (SPE) instruments and bring smart application-specific kits, ready to use pre-developed methods, and the highest level of scientific support to scientists... Read more
Visualizing the brain ultrastructure with ZEISS microscopes News The MPFI Electron Microscopy (EM) Core Facility of Max Planck Florida Institute for Neuroscience (MPFI) now is a ZEISS labs@location partner institution. MPFI will have access to state-of-the-art ZEISS technology before it is commercially available, providing researchers with innovative imaging tools that will empower their search for new insights... Read more